Dr. Matthias Glawe has been working as a specialist in nuclear medicine since 2006 with his own practice in Hamburg. He is the brains behind the technical development of the biosensor. With his interest in digital developments and his medical expertise as a nuclear cardiologist, he recognised early on the new opportunities that digital stroke screening can offer and developed a trend-setting solution.
Dr. Glawe is a graduate in human medicine. Since 2011, he has been responsible for networking, digitisation and telemedicine as a partner at the Cardiologicum Hamburg.